Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Classes and Categories01:25

Drug Classes and Categories

3.1K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
3.1K
Antibody Structure and Classes01:25

Antibody Structure and Classes

9.3K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
9.3K
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

1.9K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.9K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

1.9K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.9K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

3.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
3.3K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

2.4K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

A Career Defined by AIDS.

IAVI report : newsletter on international AIDS vaccine research·2018
Same authorSame journal

Act Now or Risk HIV Rebounding.

IAVI report : newsletter on international AIDS vaccine research·2018
Same journal

Europe Invests in HIV Vaccine Research.

IAVI report : newsletter on international AIDS vaccine research·2018
Same journal

Rallying CROI.

IAVI report : newsletter on international AIDS vaccine research·2018
Same journal

In the Epidemic's Heart.

IAVI report : newsletter on international AIDS vaccine research·2018
See all related articles

Related Experiment Video

Updated: Feb 9, 2026

Screening Foodstuffs for Class 1 Integrons and Gene Cassettes
09:37

Screening Foodstuffs for Class 1 Integrons and Gene Cassettes

Published on: June 19, 2015

9.5K

Best in Class.

Kristen Jill Kresge

    IAVI Report : Newsletter on International AIDS Vaccine Research
    |June 15, 2018
    PubMed
    Summary
    This summary is machine-generated.

    A new antibody, N6, demonstrates exceptional breadth and potency against HIV. It neutralizes 98% of HIV isolates, offering a powerful new tool in the fight against the virus.

    Area of Science:

    • Immunology
    • Virology
    • Infectious Diseases

    Background:

    • HIV infection remains a significant global health challenge.

    More Related Videos

    A 100 KW Class Applied-field Magnetoplasmadynamic Thruster
    11:47

    A 100 KW Class Applied-field Magnetoplasmadynamic Thruster

    Published on: December 22, 2018

    9.6K
    Induction and Assessment of Class Switch Recombination in Purified Murine B Cells
    09:49

    Induction and Assessment of Class Switch Recombination in Purified Murine B Cells

    Published on: August 13, 2010

    19.5K

    Related Experiment Videos

    Last Updated: Feb 9, 2026

    Screening Foodstuffs for Class 1 Integrons and Gene Cassettes
    09:37

    Screening Foodstuffs for Class 1 Integrons and Gene Cassettes

    Published on: June 19, 2015

    9.5K
    A 100 KW Class Applied-field Magnetoplasmadynamic Thruster
    11:47

    A 100 KW Class Applied-field Magnetoplasmadynamic Thruster

    Published on: December 22, 2018

    9.6K
    Induction and Assessment of Class Switch Recombination in Purified Murine B Cells
    09:49

    Induction and Assessment of Class Switch Recombination in Purified Murine B Cells

    Published on: August 13, 2010

    19.5K
  • Broadly neutralizing antibodies (bNAbs) are crucial for developing effective HIV therapies.
  • The discovery of novel bNAbs with enhanced properties is a key research area.